Conference Coverage

Diabetes prevention diet may lower mortality risk in breast cancer


 

FROM SABCS 2020

Will patients do what’s good for them?

While this study adds to the body of evidence linking diet and cancer, putting the information into action is another story, according to Halle Moore, MD, of the Cleveland Clinic, who was not involved in this study.

“We have had supportive data for the role of diet in general health outcomes, including cancer-related outcomes, for a long time. But getting the public to implement these dietary changes is a challenge, so certainly the more convincing data that we have and the more specific we can be with specific types of dietary interventions, it does make it more helpful to counsel patients,” Dr. Moore said in an interview.

She said the finding that dietary change post diagnosis can have a significant effect on lowering both all-cause and breast cancer–specific mortality is compelling evidence for a role of diet in breast cancer outcomes.

In the question-and-answer session following Dr. Wang’s presentation, Hans-Christian Kolberg, MD, from Marienhospital Bottrop at the University of Duisburg-Essen (Germany), echoed the sentiment when he commented, “you have an important result that you did not mention in the conclusion: It is not too late to change diet after breast cancer diagnosis!”

This study was supported, in part, by grants from the National Cancer Institute, Breast Cancer Research Foundations, and Susan G. Komen Breast Cancer Foundations. Dr. Wang, Dr. Moore, and Dr. Kolberg reported no relevant conflicts of interest.

SOURCE: Wang T et al. SABCS 2020, Abstract GS2-09.

Pages

Recommended Reading

Aspirin may accelerate cancer progression in older adults
MDedge Internal Medicine
Hair dye and cancer study ‘offers some reassurance’
MDedge Internal Medicine
AI algorithm on par with radiologists as mammogram reader
MDedge Internal Medicine
An oncologist’s view on screening mammography
MDedge Internal Medicine
Breast cancer screening complexities
MDedge Internal Medicine
NCI may ‘kill’ major mammography trial, says adviser
MDedge Internal Medicine
Combined features of benign breast disease tied to breast cancer risk
MDedge Internal Medicine
Thermography plus software shows efficacy for breast cancer screening
MDedge Internal Medicine
New estimates for breast cancer risk with HRT
MDedge Internal Medicine
monarchE: Abemaciclib reigns on in high-risk breast cancer
MDedge Internal Medicine